在高脂肪饮食诱导的超脂血症中识别潜在的致病性肝超增强剂监管网络

Yingying Hu1, Run Xu1, Jing Feng1

  • 1Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China and Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.

概括

超级增强剂 (SE) 调节参与高脂血症 (HLP) 的基因. 这项研究确定了HPL特定的SE和监管网络,揭示了HPL和心血管疾病的潜在治疗点.